Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.33 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL27949760 | 0.83 | MGAM (0.52) | KDM4ELMNAMGAMGAASI | |
| SCHEMBL13169650 | 0.83 | — | — | |
| SCHEMBL2148 | 0.83 | — | — | |
| SCHEMBL12140935 | 0.83 | — | — | |
| Acetic Acid SCHEMBL7017383 | 0.80 | MGAM (0.57) | KDM4ELMNAMGAMGAASI | |
| Acetic Acid SCHEMBL27471902 | 0.80 | MGAM (0.57) | KDM4ELMNAMGAMGAASI | |
| Glycine SCHEMBL3455209 | 0.80 | GLRA1 (0.56) | KDM4ELMNAMGAMGAASI | |
| Oxalic Acid SCHEMBL30540157 | 0.80 | LMNA (0.50) | KDM4ELMNAMGAMGAASI | |
| Acetic Acid SCHEMBL19468 | 0.80 | MGAM (0.57) | KDM4ELMNAMGAMGAASI | |
| SCHEMBL4649402 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9227995-B2 | Peptides | Jacobsen, Øyvind (NO) | 2016-01-05 | — | — | US | disclosed |
| CN-104507899-A | Phenol derivative, preparation method and medical application thereof | SICHUAN HAISCO PHARMACEUTICAL CO LTD | 2015-04-08 | — | — | CN | disclosed |
| US-8710008-B2 | Compounds, compositions and use | UNIVERSITETET I OSLO (NO) | 2014-04-29 | — | — | US | disclosed |
| US-20120245094-A1 | COMPOUNDS, COMPOSITIONS AND USE | UNIVERSITETET I OLSO (NO) | 2012-09-27 | — | — | US | disclosed |
| US-20110263479-A1 | Peptides | UNIVERSITETET I OSLO (NO) | 2011-10-27 | — | — | US | disclosed |
| EP-2379589-A2 | COMPOUNDS, COMPOSITIONS AND USE | Universitetet I Oslo (NO) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010073009-A2 | COMPOUNDS, COMPOSITIONS AND USE | UNIVERSITETET I OSLO (NO) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120245094-A1 | COMPOUNDS, COMPOSITIONS AND USE | VIP, C9, NGLY1 | KDM4E 4528/4885LMNA 446/4885MGAM 4272/4885 |
| US-20110263479-A1 | Peptides | VIP, NGLY1, NPPA | KDM4E 4632/4885LMNA 2903/4885MGAM 3667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.